Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

56.63
Delayed Data
As of Dec 13
 +1.76 / +3.21%
Today’s Change
11.41
Today|||52-Week Range
56.87
+361.53%
Year-to-Date

Today’s Trading

Previous close54.87
Today’s open54.55
Day’s range54.01 - 56.87
Volume1,873,168
Average volume (3 months)1,867,209
Market cap$8.6B
Data as of 4:00pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)-80.33%
Earnings growth (this year)+32.21%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)-28.32%
P/E ratioNM
Price/Sales10.35
Price/Book95.40

Competitors

 Today’s
change
Today’s
% change
ONCESpark Therapeutics I...+1.15+2.58%
AVXSAveXis Inc+4.68+5.00%
XONIntrexon Corp+0.46+3.61%
BPMCBlueprint Medicines ...+0.18+0.22%
Data as of 4:02pm ET, 12/13/2017

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$165.4M
Annual profit (last year)-$153.5M
Net profit margin-92.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts